"Dark" carbon dots specifically "light-up" calcified zebrafish bones

Area of Science:

• Biomedical engineering
• Nanotechnology
• Molecular imaging

Background:

• Bone structure and function can be compromised by disease, injury, and aging.
• In vivo bone imaging is crucial for diagnosing bone-related conditions.
• Advances in fluorescence imaging necessitate new bone-specific imaging materials.

Purpose of the Study:

• To develop novel nanomaterials for in vivo bone imaging.
• To evaluate the efficacy and safety of carbon dot nanoparticles (C-dots) for bone visualization.
• To explore the potential of C-dots as bone-targeted drug delivery vehicles.

Main Methods:

• Synthesized "dark" carbon dot nanoparticles (C-dots) with low quantum yield.
• Administered C-dots to live zebrafish larvae for in vivo imaging.
• Assessed C-dot binding affinity, selectivity, luminescence enhancement, and retention in bone structures.
• Evaluated C-dot toxicity and their utility as a carrier for fluorescein delivery to bone.

Main Results:

• "Dark" C-dots exhibited high affinity and selectivity for calcified bone structures in zebrafish larvae.
• C-dot binding significantly enhanced luminescence specifically in bone, distinguishing it from other tissues.
• C-dots demonstrated stable, long-lasting retention in bone with no detectable toxicity.
• C-dots successfully delivered fluorescein to bone, indicating potential as drug carriers.

Conclusions:

• Carbon dot nanoparticles represent a revolutionary bioagent for specific in vivo bone imaging and diagnosis.
• C-dots offer a promising platform for targeted drug delivery to bone structures.
• This study highlights the potential of "dark" C-dots in advancing bone diagnostics and therapeutics.